https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=31898045&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 318980452021041420210414
1708-04283042020AprObesity surgeryObes SurgImpact of Gastric Bypass on Erosive Esophagitis and Barret's Esophagus.119411991194-119910.1007/s11695-019-04333-1The association between gastroesophageal reflux disease (GERD) and obesity is clearly defined. The incidence of erosive esophagitis (EE) and Barrett's esophagus (BE) are as high as 26 and 6%, respectively. Gastric bypass (GBP) is considered the gold standard for obese patients with GERD. Evidence about the impact of GBP on EE and BE is not yet clear but more inspiring every day.Obese patients operated by GBP with EE or BE were included for this study. Demographics, BMI, %EWL, and the evolution of EE and BE with pre and postoperative upper endoscopy were analyzed.In this study, 64 patients were included, 55 with EE and 9 with BE. The preoperative BMI was 44.29 km/m2 ± 3.5 and the %EWL was 78.5 ± 5.8 in the first year postoperative. Preoperatively, EE was distributed as follows: A: 54.5% (30), B: 34.5% (19), C: 9% (5), D: 2% (1). BE findings were the following: short segment (SSBE): 45% (4) and long segment (LSBE): 55% (5). Postoperatively, 80% of the patients with EE resolved their condition, 11% improved, 7% had no changes, and 2% worsened. From the patients with SSBE, 75% resolved their condition and 40% with LSBE resolved their condition after 24 months and no patient progressed to dysplasia.Patients with EE had a statistically significant resolution after GBP. BE was improved or even resolved in many patients without acquiring significance but also without progression. Long-term surveillance data is necessary to define the certain evolution of EE and BE after GBP.SignoriniFrancoF0000-0002-4616-9704General Surgery Department, Bariatric Surgery Program, Hospital Privado Universitario de Córdoba, Naciones Unidas 346, 5016, Córdoba, Argentina. fransign@hotmail.com.ViscidoGermanGGeneral Surgery Department, Bariatric Surgery Program, Hospital Privado Universitario de Córdoba, Naciones Unidas 346, 5016, Córdoba, Argentina.BoccoMaría Cecilia AnastasíaMCAGeneral Surgery Department, Bariatric Surgery Program, Hospital Privado Universitario de Córdoba, Naciones Unidas 346, 5016, Córdoba, Argentina.ObeideLucioLGeneral Surgery Department, Bariatric Surgery Program, Hospital Privado Universitario de Córdoba, Naciones Unidas 346, 5016, Córdoba, Argentina.MoserFedericoFGeneral Surgery Department, Bariatric Surgery Program, Hospital Privado Universitario de Córdoba, Naciones Unidas 346, 5016, Córdoba, Argentina.engJournal Article
United StatesObes Surg91067140960-8923IMBarrett EsophagussurgeryEsophagitisGastric BypassHumansObesity, MorbidsurgeryBariatric surgeryBarret esophagusErosive EsophagitisGastric by passObese
2020146020214156020201460ppublish3189804510.1007/s11695-019-04333-110.1007/s11695-019-04333-1Arq Bras Cir Dig. 2016 Mar;29(1):33-727120737J Gastrointest Surg. 2005 Sep-Oct;9(7):949-5416137590World J Gastroenterol. 2010 Aug 14;16(30):3757-6120698037Am J Surg. 2004 Jul;188(1):27-3315219481Adv Surg. 2012;46:255-6822873044Surg Endosc. 2017 Apr;31(4):1849-185427553805Surg Endosc. 2018 Feb;32(2):930-93628779257Obes Surg. 2004 Jun-Jul;14(6):744-915318976Surg Obes Relat Dis. 2008 Jan-Feb;4(1):1-4; discussion 4-518069070Dis Esophagus. 2001;14(1):50-311422306Am J Gastroenterol. 2005 Jun;100(6):1243-5015929752Surg Endosc. 2007 Nov;21(11):1978-8417623236Am Surg. 2005 Nov;71(11):950-3; discussion 953-416372614Ann Surg. 2001 Oct;234(4):532-8; discussion 538-911573046Surg Endosc. 2017 Jan;31(1):410-41527287901World J Surg. 2009 Oct;33(10):2034-819404705Am J Gastroenterol. 2006 Nov;101(11):2619-2816952280Surg Endosc. 2012 Jan;26(1):86-9521863377Ann Surg. 2003 Oct;238(4):458-64; discussion 464-614530718Br J Surg. 2010 Jun;97(6):845-5220473997Obes Surg. 2007 Jul;17(7):894-90017894148Surg Endosc. 2001 Sep;15(9):986-911443428Gut. 1999 Aug;45(2):172-8010403727Gut. 2007 Jun;56(6):749-5517127706Surg Endosc. 2002 Jul;16(7):1027-3111984683J Gastrointest Surg. 2009 Jun;13(6):1064-7019259752Ann Surg. 2010 Feb;251(2):244-820010088Obes Surg. 2007 Jan;17(1):28-3417355765Updates Surg. 2018 Sep;70(3):331-33730143983J Natl Cancer Inst. 2014 Sep 30;106(11):25269698Surg Endosc. 2003 Dec;17(12):2003-1114577029Surg Endosc. 2006 Feb;20(2):230-416341568Surg Endosc. 2014 Dec;28(12):3279-8424935200Obes Surg. 2016 Apr;26(4):718-2026979967Gut Liver. 2009 Dec;3(4):276-8420431761Surg Obes Relat Dis. 2014 May-Jun;10(3):502-724238733Int Surg. 2011 Apr-Jun;96(2):95-10322026298J Gastrointest Surg. 2006 Feb;10(2):259-6416455459Obes Surg. 2013 Jun;23(6):736-923585025JSLS. 2004 Jan-Mar;8(1):19-2314974657Obes Surg. 2012 May;22(5):764-7222392129Am J Gastroenterol. 2008 Aug;103(8):2111-2218796104Surg Obes Relat Dis. 2014 May-Jun;10(3):411-7; quiz 565-624951067Aliment Pharmacol Ther. 2005 Nov 15;22(10):1005-1016268976Arq Bras Cir Dig. 2012 Oct-Dec;25(4):245-923411923N Engl J Med. 2014 Aug 28;371(9):836-4525162890Gastroenterology. 1993 Jul;105(1):40-508514061Obes Surg. 2009 Apr;19(4):427-3118795381